Abstract:Neurofibromatosis type 1 (NF1) is a common monogenic neurodevelopmental disorder associated with physical and cognitive problems. The cognitive issues are thought to arise from increased release of the neurotransmitter GABA. Modulating the signaling pathways causing increased GABA release in a mouse model of NF1 reverts deficits in hippocampal learning. However, clinical trials based on these approaches have so far been unsuccessful. We therefore used a combination of slice electrophysiology, in vivo two-photon calcium imaging, and optical imaging of intrinsic signal in a mouse model of NF1 to investigate whether cortical development is affected in NF1, possibly causing lifelong consequences that cannot be rescued by reducing inhibition later in life. We find that, in NF1 mice of both sexes, inhibition increases strongly during the development of the visual cortex and remains high. While this increase in cortical inhibition does not affect spontaneous cortical activity patterns during early cortical development, the critical period for ocular dominance plasticity is shortened in NF1 mice due to its early closure but unaltered onset. Notably, after environmental enrichment, differences in inhibitory innervation and ocular dominance plasticity between NF1 mice and WT littermates disappear. These results provide the first evidence for critical period dysregulation in NF1 and suggest that treatments aimed at normalizing levels of inhibition will need to start at early stages of development. SIGNIFICANCE STATEMENT Neurofibromatosis type 1 is associated with cognitive problems for which no treatment is currently available. This study shows that, in a mouse model of neurofibromatosis type 1, cortical inhibition is increased during development and critical period regulation is disturbed. Rearing the mice in an environment that stimulates cognitive function overcomes these deficits. These results uncover critical period dysregulation as a novel mechanism in the pathogenesis of neurofibromatosis type 1. This suggests that targeting the affected signaling pathways in neurofibromatosis type 1 for the treatment of cognitive disabilities may have to start at a much younger age than has so far been tested in clinical trials.

Distinct Functional Domains of Neurofibromatosis Type 1 Regulate Immediate Versus Long-Term Memory Formation

A neurofibromatosis-1-regulated pathway is required for learning in Drosophila

Associative Learning Requires Neurofibromin to Modulate GABAergic Inputs to Drosophila Mushroom Bodies

Molecular and Cellular Mechanisms of Learning Disabilities: a Focus on NF1.

Neurofibromin Regulates G Protein–stimulated Adenylyl Cyclase Activity

Effect of Neurofibromatosis Type I Mutations on a Novel Pathway for Adenylyl Cyclase Activation Requiring Neurofibromin and Ras.

Calmodulin Shuttling Mediates Cytonuclear Signaling to Trigger Experience-Dependent Transcription and Memory

NF1 regulation of RAS/ERK signaling is required for appropriate granule neuron progenitor expansion and migration in cerebellar development.

Mechanistic insights from animal models of neurofibromatosis type 1 cognitive impairment

Neurofibromin Loss of Function Drives Excessive Grooming in Drosophila

Disruption of Critical Period Plasticity in a Mouse Model of Neurofibromatosis Type 1

Gender-Specific Fine Motor Skill Learning Is Impaired by Myelin-Targeted Neurofibromatosis Type 1 Gene Mutation

Transient Inhibition of the Erk Pathway Prevents Cerebellar Developmental Defects and Improves Long-Term Motor Functions in Murine Models of Neurofibromatosis Type 1

Drosophila Contributions towards Understanding Neurofibromatosis 1

Neurofibromin deficiency alters the patterning and prioritization of motor behaviors in a state-dependent manner

The neurofibromin GAP-related domain rescues endothelial but not neural crest development in Nf1 mice

Fragile X Mental Retardation Protein is Required for Chemically‐induced Long‐term Potentiation of the Hippocampus in Adult Mice

Fibroblast growth factor receptor-1 is required for long-term potentiation, memory consolidation, and neurogenesis.

CNS Glial Progenitors and Schwann Cells in Neurofibromatosis Type 1

The cryo-EM structure of the neurofibromin dimer reveals the molecular basis for von Recklinghausen disease

The cryo-EM structure of the human neurofibromin dimer reveals the molecular basis for neurofibromatosis type 1